Skeletal muscle-specific overexpression of SIRT1 does not enhance whole-body energy expenditure or insulin sensitivity in young mice

Diabetologia

Volumn 56, Issue 7, 2013, Pages 1629-1637

  White, A T ^a,b   McCurdy, C E ^c   Philp, A ^d   Hamilton, D L ^e   Johnson, C D ^a   Schenk, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Children's Hospital Colorado   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

2 Deoxyglucose uptake; Energy restriction; Insulin sensitivity; SIRT1; Skeletal muscle

Indexed keywords

ADENYLATE KINASE; DEOXYGLUCOSE; GLUCOSE; INSULIN; ISOPHANE INSULIN; MESSENGER RNA; SIRTUIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME ACTIVITY; EX VIVO STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; GENE; GENE OVEREXPRESSION; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIRT GENE; SKELETAL MUSCLE; SOLEUS MUSCLE;

ANIMALS; BODY COMPOSITION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENERGY METABOLISM; GENOTYPE; INSULIN RESISTANCE; MICE; MUSCLE, SKELETAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1;

EID: 84878885257     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2912-2     Document Type: Article

References (34)

1. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89-94
2. Houtkooper RH, Canto C, Wanders RJ, Auwerx J (2010) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31:194-223
3. Yu J, Auwerx J (2010) Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation. Pharmacol Res 62:35-41
4. Banks AS, Kon N, Knight C et al (2008) SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 8:333-341
5. Bordone L, Cohen D, Robinson A et al (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6:759-767
6. Feige JN, Lagouge M, Canto C et al (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8:347-358
7. Milne JC, Lambert PD, Schenk S et al (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712-716
8. Frojdo S, Durand C, Molin L et al (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 335:166-176
9. Sun C, Zhang F, Ge X et al (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307-319
10. Schenk S, McCurdy CE, Philp A et al (2011) Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J Clin Invest 121:4281-4288
11. Cartee GD, Dean DJ (1994) Glucose transport with brief dietary restriction: heterogenous responses in muscles. Am J Physiol 266:E946-E952
12. McCurdy CE, Cartee GD (2005) Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. Diabetes 54:1349-1356
13. Firestein R, Blander G, Michan S et al (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 3:e2020
14. McGee SL, Mustard KJ, Hardie DG, Baar K (2008) Normal hypertrophy accompanied by phosphorylation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice. J Physiol 586:1731-1741
15. Bruss MD, Khambatta CF, Ruby MA, Aggarwal I, Hellerstein MK (2010) Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am J Physiol Endocrinol Metab 298:E108-E116
16. Yi J, Luo J (2010) SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 1804:1684-1689
17. Yoshizaki T, Schenk S, Imamura T et al (2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298:E419-E428
18. Yoshizaki T, Milne JC, Imamura T et al (2009) SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 29:1363-1374
19. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363-374
20. Sharma N, Arias EB, Bhat AD et al (2011) Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted rats. Am J Physiol Endocrinol Metab 300:E966-E978
21. Nogueiras R, Habegger KM, Chaudhary N et al (2012) Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 92:1479-1514
22. Menzies KJ, Hood DA (2012) The role of SirT1 in muscle mitochondrial turnover. Mitochondrion 12:5-13
23. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA 105:9793-9798
24. Boily G, Seifert EL, Bevilacqua L et al (2008) SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 3:e1759
25. Ramadori G, Fujikawa T, Fukuda M et al (2010) SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab 12:78-87
26. Lan F, Cacicedo JM, Ruderman N, Ido Y (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283:27628-27635
27. Suchankova G, Nelson LE, Gerhart-Hines Z et al (2009) Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 378:836-841
28. Hou X, Xu S, Maitland-Toolan KA et al (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015-20026
29. Canto C, Gerhart-Hines Z, Feige JN et al (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056-1060
30. Canto C, Jiang LQ, Deshmukh AS et al (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11:213-219
31. Palacios OM, Carmona JJ, Michan S et al (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 1:771-783
32. Wang P, Zhang RY, Song J et al (2012) Loss of AMP-activated protein kinase-alpha2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes 61:1051-1061
33. Gonzalez AA, Kumar R, Mulligan JD, Davis AJ, Weindruch R, Saupe KW (2004) Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. Am J Physiol Endocrinol Metab 287:E1032-E1037
34. Philp A, Chen A, Lan D et al (2011) Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation following endurance exercise. J Biol Chem 286:30561-30570